Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress
NCT06999109 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2025-06-05
Summary
The objectives of this study are to determine if the 'Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress' (TEAM-LEADS) intervention is feasible and acceptable to adolescents and young adults with lupus and dermatomyositis and whether it can help reduce stress and promote cardiovascular health behaviors in these individuals.
Conditions
- Lupus
- Dermatomyositis, Juvenile
- Dermatomyositis
- Lupus Erythematosus
- Lupus Erythematosus, Systemic
- Lupus or SLE
Interventions
- BEHAVIORAL
-
TEAM-LEADS
TEAM-LEADS will be an online, self-administered intervention for stress reduction and cardiovascular health behavior promotion in adolescents and young adults with juvenile-onset systemic lupus erythematosus and dermatomyositis
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Kaveh Ardalan, MD, MS · Duke University
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 12 Years
- Max Age
- 22 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2027-01-31
- Primary Completion
- 2028-12-31
- Completion
- 2028-12-31
Countries
- United States
Study Locations
More Related Trials
-
Intervention to Improve Quality of Life in African American Lupus Patients
NCT01837875 ·Status: COMPLETED ·Phase: NA
-
Reducing Depressive Symptoms in Systemic Lupus Erythematosus
NCT01120652 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Systemic Lupus Erythematosus
NCT06429800 ·Status: WITHDRAWN ·Phase: PHASE1
-
Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention
NCT00189124 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The HOP-STEP Intervention: Improving Maternal Health in Women With Lupus sIRB
NCT05818254 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
A Clinical Study of CD19 CAR-T in Active Systemic Lupus Erythematosus
NCT06106906 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Use of Social Media to Improve Medication Adherence in Adolescents and Young Adults With Systemic Lupus
NCT03218033 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus
NCT00657189 ·Status: COMPLETED ·Phase: PHASE2
-
Psycho-social Consequences of Systemic Lupus Erythematosus
NCT03913754 ·Status: COMPLETED
-
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
NCT00342095 ·Status: COMPLETED
-
Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus
NCT02319525 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study of CD19 Universal CAR-γδT Cells in Active Systemic Lupus Erythematosus
NCT06106893 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)
NCT00317681 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus
NCT01629784 ·Status: COMPLETED ·Phase: NA
-
Addressing Disparities in Lupus Care Through an Integrated Care Management Program
NCT03915652 ·Status: COMPLETED ·Phase: NA
-
Reducing Disparities in Medication Adherence in SLE
NCT03738826 ·Status: COMPLETED ·Phase: NA
-
Balancing Lupus Experiences With Stress Strategies
NCT01351662 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
NCT06839976 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Whole Health Empowerment for Endotypes of Lupus: Improving Quality of Life in SLE
NCT06720584 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus.
NCT03958955 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of LY2127399 in Participants With Systemic Lupus Erythematosus
NCT01196091 ·Status: COMPLETED ·Phase: PHASE3
-
Motivating Individuals With Lupus to Exercise
NCT05287581 ·Status: COMPLETED ·Phase: NA
-
Duke Autoimmunity in Pregnancy Registry
NCT00513591 ·Status: COMPLETED
-
Complete Cognitive Intervention for cSLE
NCT07302113 ·Status: RECRUITING ·Phase: NA